Results 11 to 20 of about 1,295 (151)

Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection [PDF]

open access: yesCase Reports in Transplantation, 2017
Background. Cytomegalovirus (CMV) antiviral drug resistance constitutes an increasing challenge in transplantation. Foscarnet is usually proposed when resistance for ganciclovir is suspected, but its use is limited by its nephrotoxicity.
Romain Vial   +9 more
doaj   +2 more sources

Foscarnet Versus Ganciclovir for Severe Congenital Cytomegalovirus Infection: Short- and Long-Term Follow-Up

open access: yesViruses
Background: Cytomegalovirus (CMV) infection is the most common and serious congenital infection, with universal screening in pregnancy, standardized therapy, and a vaccine still lacking.
Giovanni Nigro   +4 more
doaj   +2 more sources

Foscarnet-Resistant Cytomegalovirus Esophagitis with Stricturing

open access: yesCase Reports in Gastroenterology, 2013
We report the case of a 52-year-old man with HIV-AIDS, non-complaint with highly active antiretroviral therapy, who presented with long-standing dysphagia.
Vinaya Gaduputi   +4 more
doaj   +2 more sources

Foscarnet Decreases Human Immunodeficiency Virus RNA [PDF]

open access: yes, 1995
Foscarnet inhibits human immunodeficiency virus (HIV) replication in vitro and decreases p24 antigenemia in patients with cytomegalovirus (CMV) retinitis.
H. Furrer   +13 more
core   +3 more sources

Foscarnet-Type Inorganic-Organic Hybrid Nanoparticles for Effective Antiviral Therapy

open access: yes, 2022
[ZrO]2+[(FCN)0.4(OH)0.8]2– and Gd3+[FCN]3– inorganic-organic hybrid nanoparticles (IOH-NPs) are novel saline antiviral nanocarriers with foscarnet (FCN) as a drug anion.
Mikhail Khorenko   +7 more
core   +1 more source

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients [PDF]

open access: yes, 2004
Forty-eight patients who provided 2 consecutive blood samples that tested positive for cytomegalovirus DNA by polymerase chain reaction (PCR) were randomized to receive either full-dose ganciclovir ( 5 mg/kg intravenously [iv] twice daily) or half-dose ...
Potter, M   +31 more
core   +1 more source

33111 New onset scrotal lesions in a patient with herpes simplex virus treated with foscarnet [PDF]

open access: yes, 2022
Introduction: Intravenous (IV) foscarnet is used for the treatment of acyclovir-resistant herpes simplex virus (HSV). Foscarnet-induced penile ulcerations, thought to be due to an irritant contact dermatitis, can occur where urine contacts the skin, such
Wang, Rebecca F, Friedman, Ben J
core   +1 more source

Analysis of cytomegalovirus resistance mutations and clinical features of CMV infection in immunocompromised children [PDF]

open access: yesКлиническая микробиология и антимикробная химиотерапия
Objective. To determine frequency and spectrum of cytomegalovirus (CMV) resistance mutations to antiviral drugs in immunocompromised children. To study clinical course of resistant CMV infection in this patient population. Materials and Methods. This
Kozhushnaya O.S.   +4 more
doaj   +1 more source

Successful Treatment of Epstein-Barr Virus-Induced Necrotizing Retinitis with Intravitreous Ganciclovir, Foscarnet, and Methotrexate

open access: yesCase Reports in Ophthalmology, 2022
This is a report of an immunocompromised 49-year-old renal transplant patient with Epstein-Barr virus (EBV)-induced necrotizing retinitis (NR). The patient with NR underwent diagnostic vitrectomy.
Junsang Cho   +5 more
doaj   +1 more source

Foscarnet Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection in Kidney Transplant Recipients: A Preliminary Exploration

open access: yesInfection and Drug Resistance, 2021
Yedong Yu,1 Ruijie Bao,1 Junhao Lyu,1– 4 Jianyong Wu,1– 4 Jianghua Chen,1– 4 Wenhan Peng1– 4 1Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China; 2Department of ...
Yu Y, Bao R, Lyu J, Wu J, Chen J, Peng W
doaj  

Home - About - Disclaimer - Privacy